ESMO Sarcoma And Rare Cancers 2025

Great experience at the ESMO Sarcoma and Rare Cancers Congress 2025! Our Genomic and Trascriptomic team contributed 3 posters, 2 oral presentations, and an interview, focusing on our research in glioblastoma and osteosarcoma.